Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ependymomas.

Marc C Chamberlain1

  • 1Department of Neurology, USC/Norris Cancer Center, 1441 Eastlake Avenue, Suite 3459, Los Angeles, CA 90033-0804, USA. chamberl@usc.edu

Current Neurology and Neuroscience Reports
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Complete surgical resection is crucial for newly diagnosed ependymoma, a rare central nervous system (CNS) tumor. Intensifying initial adjuvant treatment may help prevent tumor recurrence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Neuro-oncology advances·2022
Same author

"You can observe a lot by just watching" (Yogi Berra).

Neuro-oncology·2021
Same author

Leptomeningeal metastases: how best to assess response.

Neuro-oncology·2020
Same author

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Neuro-oncology·2018
Same author

Leptomeningeal metastasis.

Handbook of clinical neurology·2018
Same author

Immunochemotherapy, the New Standard of Care for Primary CNS Lymphoma: However, Which One?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2017

Area of Science:

  • Neuro-oncology
  • Central Nervous System (CNS) Neoplasms

Background:

  • Ependymomas are rare central nervous system (CNS) neoplasms.
  • Limited randomized clinical trials exist, impacting treatment guidelines.

Purpose of the Study:

  • To review and establish treatment guidelines for ependymoma based on existing literature.
  • To identify optimal management strategies for newly diagnosed and recurrent ependymoma.

Main Methods:

  • Literature review of ependymoma treatment.
  • Analysis of prognostic significance of complete tumor resection.
  • Evaluation of adjuvant therapies including radiotherapy and chemotherapy.

Main Results:

  • Complete resection, confirmed by MRI, is the primary management for newly diagnosed ependymoma.

Related Experiment Videos

  • Incomplete resection warrants a second surgical attempt.
  • Radiotherapy is indicated for residual disease; craniospinal irradiation for metastatic disease.
  • Chemotherapy's role is uncertain, reserved for refractory cases.

    • Conclusions:

    • Complete surgical resection is paramount for favorable outcomes in ependymoma.
    • Adjuvant radiotherapy decisions depend on residual disease and metastasis.
    • Preventing relapse may involve intensifying initial adjuvant therapies due to poor survival post-recurrence.